WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.25), $0.04 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $19.69 million versus the consensus estimate of $19.45 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.